Cargando…
Eltrombopag: a new treatment option for chronic refractory adult immune thrombocytopenia
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377332/ https://www.ncbi.nlm.nih.gov/pubmed/25830121 http://dx.doi.org/10.5045/br.2015.50.1.1 |
_version_ | 1782363884994166784 |
---|---|
author | Park, Rojin |
author_facet | Park, Rojin |
author_sort | Park, Rojin |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4377332 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis |
record_format | MEDLINE/PubMed |
spelling | pubmed-43773322015-03-31 Eltrombopag: a new treatment option for chronic refractory adult immune thrombocytopenia Park, Rojin Blood Res Editorial Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2015-03 2015-03-24 /pmc/articles/PMC4377332/ /pubmed/25830121 http://dx.doi.org/10.5045/br.2015.50.1.1 Text en © 2015 Korean Society of Hematology http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Editorial Park, Rojin Eltrombopag: a new treatment option for chronic refractory adult immune thrombocytopenia |
title | Eltrombopag: a new treatment option for chronic refractory adult immune thrombocytopenia |
title_full | Eltrombopag: a new treatment option for chronic refractory adult immune thrombocytopenia |
title_fullStr | Eltrombopag: a new treatment option for chronic refractory adult immune thrombocytopenia |
title_full_unstemmed | Eltrombopag: a new treatment option for chronic refractory adult immune thrombocytopenia |
title_short | Eltrombopag: a new treatment option for chronic refractory adult immune thrombocytopenia |
title_sort | eltrombopag: a new treatment option for chronic refractory adult immune thrombocytopenia |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377332/ https://www.ncbi.nlm.nih.gov/pubmed/25830121 http://dx.doi.org/10.5045/br.2015.50.1.1 |
work_keys_str_mv | AT parkrojin eltrombopaganewtreatmentoptionforchronicrefractoryadultimmunethrombocytopenia |